SCN9A Gene Dravet Syndrome Modifier of Genetic Test
Components: SCN9A Gene Dravet syndrome modifier of Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SCN9A Gene Dravet syndrome, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN9A Gene Dravet syndrome, modifier of.
Test Details: The SCN9A gene is one of the genes that has been linked to Dravet syndrome, a severe form of epilepsy that usually begins in infancy. This gene provides instructions for making a protein that helps to transmit signals between nerve cells. Mutations in the SCN9A gene can cause a dysfunction in the protein, leading to abnormal nerve cell activity and seizures. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This type of testing can identify mutations in the SCN9A gene and other genes associated with Dravet syndrome. Modifiers are genetic factors that can influence the severity or expression of a disease. In the case of Dravet syndrome, modifiers may affect the age of onset, frequency, and severity of seizures. Identifying modifiers can help doctors predict the course of the disease and develop more targeted treatments. Overall, NGS genetic testing can provide valuable information for diagnosing Dravet syndrome and identifying potential modifiers. This information can help doctors develop personalized treatment plans for patients with this condition.
Test Name | SCN9A Gene Dravet syndrome modifier of Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SCN9A Gene Dravet syndrome, modifier of NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN9A Gene Dravet syndrome, modifier of |
Test Details |
The SCN9A gene is one of the genes that has been linked to Dravet syndrome, a severe form of epilepsy that usually begins in infancy. This gene provides instructions for making a protein that helps to transmit signals between nerve cells. Mutations in the SCN9A gene can cause a dysfunction in the protein, leading to abnormal nerve cell activity and seizures. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes simultaneously. This type of testing can identify mutations in the SCN9A gene and other genes associated with Dravet syndrome. Modifiers are genetic factors that can influence the severity or expression of a disease. In the case of Dravet syndrome, modifiers may affect the age of onset, frequency, and severity of seizures. Identifying modifiers can help doctors predict the course of the disease and develop more targeted treatments. Overall, NGS genetic testing can provide valuable information for diagnosing Dravet syndrome and identifying potential modifiers. This information can help doctors develop personalized treatment plans for patients with this condition. |